Recently, dipeptidyl-Peptidase 6 (DPP6) was identified as a target to evaluate the endocrine cell mass in vivo, for the visualization of the progressive β-cell loss in diabetes or after islet transplantation [134]. The gene discussed is DPP6; the disease is diabetes mellitus.